44 studies found for:    pancreatic,cancer,detection | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
pancreatic,cancer,detection | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Pancreatic Cancer Early Detection Program
Conditions: Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Adenocarcinoma;   Familial Pancreatic Cancer;   BRCA 1/2;   HNPCC;   Lynch Syndrome;   Hereditary Pancreatitis;   FAMMM;   Familial Atypical Multiple Mole Melanoma;   Peutz Jeghers Syndrome
Interventions: Procedure: Endoscopic Ultrasound;   Procedure: Magnetic Resonance Imaging (MRI)
2 Recruiting Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.
Conditions: Circulating Tumor Cells;   Pancreatic Adenocarcinoma;   Circulating Tumor DNA (KRAS);   CA 19.9
Intervention: Other: Pancreatic adenocarcinoma diagnosis
3 Recruiting Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Procedure: Endoscopic Ultrasound (EUS)
4 Recruiting Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air
Condition: Pancreatic Cancer
Intervention:
5 Recruiting The Detection of CTCs in Patients With Pancreatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment.
Condition: Neoplastic Cells, Circulating
Interventions: Other: Flow cytometry  (FCM);   Other: RT-PCR
6 Recruiting Early Detection of Pancreatic Cystic Neoplasms
Conditions: Pancreatic Cysts;   Intraductal Papillary Mucinous Neoplasm;   Pancreatic Mucinous-Cystic Neoplasm;   Cystic, Mucinous and/or Serous Neoplasm;   Solid Pseudopapillary Tumour of the Pancreas
Intervention:
7 Not yet recruiting Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Conditions: Pancreatic Neoplasms;   Peutz-Jegher's Syndrome;   BRCA1 Gene Mutation;   BRCA2 Gene Mutation;   Ataxia Telangiectasia;   Familial Atypical Mole-Malignant Melanoma Syndrome;   Colorectal Neoplasms, Hereditary Nonpolyposis;   Hereditary Pancreatitis
Interventions: Other: Pancreatic Cancer Screening Pathway 1;   Other: Pancreatic Cancer Screening Pathway 2
8 Recruiting PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
Condition: Pancreatic Cancer
Intervention:
9 Recruiting Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy
Conditions: Barrett Esophagus;   Gastric Antrectomy Partial;   Biliary Duct Stricture;   Pancreatic Duct Stricture;   Colorectal Polyps;   Esophageal Epidermoid Cancer in Pts With Head and Neck Cancer
Intervention: Procedure: Confocal endomicroscopy
10 Recruiting Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer. ICORG 07-12
Conditions: Breast Cancer;   Colorectal Cancer;   Lung Cancer;   Melanoma (Skin);   Pancreatic Cancer
Intervention:
11 Recruiting Biospecimens for Identification of Diseases of the Pancreas.
Conditions: Pancreatic Cancer;   Chronic Pancreatitis;   Type II Diabetes;   Pancreatic Cysts;   Healthy Control
Intervention: Procedure: Blood Draw
12 Recruiting Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients
Conditions: Diabetes Mellitus, Adult-Onset;   Diabetes Complications;   Carcinoma, Pancreatic Ductal;   Pancreatic Neoplasm
Intervention:
13 Recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
Conditions: Breast Cancer;   Colon Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastrointestinal Cancer;   Liver and Intrahepatic Biliary Tract Cancer;   Lung Cancer;   Metastatic Cancer;   Pancreatic Cancer;   Rectal Cancer;   Thyroid Gland Medullary Carcinoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Procedure: radionuclide imaging;   Procedure: positron emission tomography;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Drug: Cu 64 anti-CEA monoclonal antibody M5A IV
14 Recruiting Quality Control Study of MR Based Screening of Individual With Increased Risk for Pancreas Cancer.
Conditions: Hereditary Pancreatitis;   Hereditary Pancreatic Cancer
Intervention: Other: MRI
15 Unknown  Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity
Condition: Pancreas Cancer
Intervention: Drug: Secretin Synthetic Human (RG1068)
16 Recruiting According CTC to Compare the Influences of Different Methods to Remove the PDAC
Conditions: Carcinoma, Pancreatic Ductal;   Circulating Tumor Cells
Interventions: Procedure: routine surgery;   Procedure: no-touch surgery;   Procedure: laparoscopic surgery
17 Recruiting Evaluation of PET-CT Using Somatostatin Agonists Labeled With Gallium68 in Neuroendocrine Tumors
Condition: Gastro-Entero-Pancreatic Tumors (GEPs)
Intervention: Other: PET-CT
18 Recruiting Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions
Conditions: Pancreatic Cysts;   Pancreatic Mucinous-Cystic Neoplasm;   Intraductal Papillary Mucinous Neoplasm;   Solid Pseudopapillary Tumour of the Pancreas;   Cystadenocarcinoma;   Serous Cystadenoma
Intervention: Procedure: Endoscopic ultrasound guided needle based confocal endomicroscopy
19 Recruiting Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)
Conditions: Prostate Cancer;   Renal Cell Carcinoma;   Bladder Cancer;   Colorectal Cancer;   Gastric Cancer;   Pancreatic Cancer;   Non-small Cell Lung Cancer
Interventions: Device: Mesenchymal-marker based ferrofluid (c-MET);   Device: Epithelial cell adhesion molecule (EpCAM) ferrofluid
20 Not yet recruiting BetaScope and LightPath Specimen Analyser Devices Imaging Study in Gastrointestinal Tumour Surgery
Conditions: Gastric Cancer;   Pancreatic Cancer;   Bile Duct Cancer;   Duodenal Cancer
Interventions: Drug: The marketed product 2-5 MBq/kg 18F-fluorodeoxyglucose;   Device: BetaScope PET tracer imaging scope;   Device: Cerenkov Luminescence Imaging LightPath Specimen Analyser

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years